Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
Showing 301–360 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
…to inhaled corticosteroids. Recent evidence supports a role for anti-eosinophilic biologic therapy in reducing exacerabations in this subgroup. FeNO is commonly u…
…s of T2 inflammation.Abstract S172 Figure 1Conclusion Objective ICS adherence influenced clinical outcomes differently by T2 phenot…
…nflammation (screening blood eosinophil count ≥300 cells/mL) on triple inhalation therapy. Patients received dupilumab 300 mg every two weeks (q2w) or pl…
…ad extended MRC dyspnoea score (eMRC [range: 1–5b]) ≥2, were on inhaled corticosteroids and had significant smoking history. Primary outcome was time t…
…hy controls, driven by the enrichment of Streptococcus. Age and reflux treatment also influenced microbial composition, with therapy for reflux …
… deterioration.Reference Harrison CH, Tupper P, Gerry S, et al. Oxygen therapy in early warning scores: a systematic review and meta-analysis.…
…51 had full metadata; 414/1851 had follow-up CT scans following therapy. 3 sites were held out for validation and to assess generalisat…
… allergens, Total IgE, blood eosinophils, and completed 8 weeks inhaled corticosteroid treatment. A panel of at least 3 asthma specialists using all available d…
…Background Biologic therapies have revolutionized severe asthma management, reducing systemic…
…e it is usually diagnosed after spreading beyond the margins of curative treatment. Clinical trials have demonstrated a reduction in deaths from l…
…ed molecular drivers. Given the scarcity of biomarkers to guide immunotherapy in TETs, we conducted an integrative analysis to characterise i…
… to determine the clinimetric properties of OE-MRI; all were on ETI therapy (>6 months at baseline). Participants performed OE-MRI, MBW ShX…